medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2024, Number 5

<< Back Next >>

Rev Mex Urol 2024; 84 (5)

“I haven’t heard of anyone I know dying from it”: perceptions on prostate cancer prevention in a group of men from Yucatan

Martin-DoraRochel-Pérez EA, Chi-Méndez CG, Bastarrachea-Solis MA, Flores-Tapia JP, Méndez-Domínguez N

Language: Spanish
References: 24
Page: 1-12
PDF size: 288.20 Kb.


ABSTRACT

Introduction: the prostate cancer it is the second cause of cancer most diagnosticated and the fifth cause of death in men; in 2019 Mexico reported a incidence of 52.3 cases and 19.4 deaths per 100 000 people respectively; it is estimated that the 70 % of the cases are diagnosticated at advanced stages.
Objective: to explore the perception of barriers and facilitators for prostate cancer prevention in a group of Yucatecan men without social security.
Material and methods: this qualitative study, conducted through focus groups, seeks to answer the question: What is needed to improve the timely diagnosis of prostate cancer in Yucatan, Mexico?
Results: participants mentioned that they do not identify the risk factors for developing prostate cancer in themselves but perceive risks in other conditions such as diabetes.
Conclusions: it is crucial to implement campaigns for the detection of prostate cancer with extramural activities, to ensure that the information reaches the potential population for these services and to incorporate experiences of patients diagnosed with prostate cancer in the detection campaigns. Rectal examination needs be destigmatized and other screening methods for early diagnosis of should be disseminated.


REFERENCES

  1. Rawla P. Epidemiology of Prostate Cancer.World Journal of Oncology. 2019;10(2): 63–89.https://doi.org/10.14740/wjon1191.

  2. Beltran-Ontiveros SA, Fernandez-GalindoMA, Moreno-Ortiz JM, Contreras-GutierrezJA, Madueña-Molina J, Arambula-Meraz E, etal. Incidence, Mortality, and Trends of ProstateCancer in Mexico from 2000 to 2019: Resultsfrom the Global Burden of Disease Study2019. Cancers. 2022;14(13): 3184. https://doi.org/10.3390/cancers14133184.

  3. Reynoso-Noverón N, Meneses-García A,Erazo-Valle A, Ríos PE de los, Kuri-MoralesPA, Mohar-Betancourt A. Challenges in thedevelopment and implementation of theNational Comprehensive Cancer ControlProgram in Mexico. Salud Pública de México.2016;58(2): 325–333.

  4. Cowman S, Cowman JG, Almumin A,Altailasan FAFM, Weathers E. Knowledgeand Attitudes of Men in Bahrain TowardProstate Cancer. Seminars in Oncology Nursing.2021;37(3): 151158. https://doi.org/10.1016/j.soncn.2021.151158.

  5. Paiva EP de, Motta MCS da, Griep RH.Barriers related to screening examinations forprostate cancer. Revista Latino-Americana DeEnfermagem. 2011;19(1): 73–80. https://doi.org/10.1590/s0104-11692011000100011.

  6. Fraser M, Koontz B, Emmenegger U, DeMeerleer G, Khoo V, Feng F, et al. What IsOligometastatic Prostate Cancer? EuropeanUrology Focus. 2019;5(2): 159–161. https://doi.org/10.1016/j.euf.2018.12.009.

  7. Mottet N, van den Bergh RCN, Briers E, Van denBroeck T, Cumberbatch MG, De Santis M, et al.EAU-EANM-ESTRO-ESUR-SIOG Guidelines onProstate Cancer-2020 Update. Part 1: Screening,Diagnosis, and Local Treatment with CurativeIntent. European Urology. 2021;79(2): 243–262.https://doi.org/10.1016/j.eururo.2020.09.042.

  8. Vapiwala N, Miller D, Laventure B, WoodhouseK, Kelly S, Avelis J, et al. Stigma, beliefs andperceptions regarding prostate cancer amongBlack and Latino men and women. BMCPublic Health. 2021;21(1): 758. https://doi.org/10.1186/s12889-021-10793-x.

  9. Foster S, Carvallo M, Wenske M, LeeJ. Damaged Masculinity: How HonorEndorsement Can Influence Prostate CancerScreening Decision-Making and Prostate CancerMortality Rates. Personality & Social PsychologyBulletin. 2023;49(2): 296–308. https://doi.org/10.1177/01461672211065293.

  10. Torres-Sánchez LE, Espinoza-Giacinto R, Rojas-Martínez R, Escamilla-Nuñez C, Vázquez-Salas RA, Campuzano JC, et al. Prostate cancermortality according to marginalization status inMexican states from 1980 to 2013. Salud Públicade México. 2016;58(2): 179–186.

  11. Hevia F. Confianza y desconfianza en el sistemapúblico de salud en México. Revista Chilena deSalud Pública. 2006;10(2): 107–111.

  12. Tristán-Martínez PD, Doubova SV, Sauceda-Valenzuela AL. Calidad de atención enpacientes con cáncer de próstata atendidos enMéxico. Revista Médica del Instituto Mexicano delSeguro Social. 2022;60(3): 275–282.

  13. Marzo-Castillejo M, Nuin-Villanueva MÁ,Vela-Vallespín C. Recomendaciones encontra del cribado de cáncer de próstatacon antígeno prostático específico. AtencionPrimaria. 2012;44(7): 377–378. https://doi.org/10.1016/j.aprim.2012.02.005.

  14. Basulto-Martínez M, Peña-Espinoza B, Valdez-Ortiz R, Escalante-Sosa R, Flores-Tapia JP,Menjivar M. High Prevalence of Hypocitraturiain Stone Formers from the Maya Region ofYucatan, Mexico. Archives of Medical Research.2022;53(1): 69–78. https://doi.org/10.1016/j.arcmed.2021.05.006.

  15. Prieto Rodríguez MA, March Cerdá JC. Pasoa paso en el diseño de un estudio mediantegrupos focales. Atencion Primaria. 2002;29(6):366–373. https://doi.org/10.1016/S0212-6567(02)70585-4.

  16. Malika N, Ogundimu O, Roberts L, Alemi Q,Casiano C, Montgomery S. African ImmigrantHealth: Prostate Cancer Attitudes, Perceptions,and Barriers. American Journal of Men’s Health.2020;14(4): 1557988320945465. https://doi.org/10.1177/1557988320945465.

  17. Mincey K, Turner BL, Anderson K, Maurice S,Neal R, White C. Prostate Knowledge, Attitudesand Beliefs in Black College Men: A QualitativeStudy. Journal of Community Health. 2017;42(6):1096–1101. https://doi.org/10.1007/s10900-017-0357-0.

  18. Alothman AM, Altamimi AF, Alhenaki AW,Almansour NM, Alhusaini AK, Alateeq F. Theknowledge and attitude towards prostate cancerand screening practices among males in SaudiArabia. Journal of Family Medicine and PrimaryCare. 2022;11(6): 2637–2642. https://doi.org/10.4103/jfmpc.jfmpc_1802_21.

  19. Erena AN, Shen G, Lei P. Prostate cancerawareness and screening practice amongKenyan men. European journal of cancerprevention: the official journal of the EuropeanCancer Prevention Organisation (ECP). 2020;29(3): 252–258. https://doi.org/10.1097/CEJ.0000000000000501.

  20. Murillo-Zamora E. Desafíos en la prevención ytratamiento del cáncer de próstata en México: unllamado a la acción. Revista Mexicana de Urología.2024;84(2): 1–2. https://doi.org/10.48193/f3wvha72.

  21. Boustany J, Abdessater M, Akl H, KanbarA, Khoury JE, Assaf S, et al. Prostate Cancerawareness in the Lebanese population: a crosssectional national survey. BMC public health.2021;21(1): 1744. https://doi.org/10.1186/s12889-021-11821-6.

  22. McPherson M, Smith-Lovin L, Cook J. Birdsof a Feather: Homophily in Social Networks |Request PDF. ResearchGate. 2024; https://doi.org/10.1146/annurev.soc.27.1.415.

  23. Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M, et al. Prevalencia deprediabetes y diabetes en México: Ensanut2022. Salud Pública de México. 2023;65: s163–s168. https://doi.org/10.21149/14832.

  24. Morlando M, Pelullo CP, Di Giuseppe G.Prostate cancer screening: Knowledge, attitudesand practices in a sample of men in Italy. A survey.PloS One. 2017;12(10): e0186332. https://doi.org/10.1371/journal.pone.0186332.




2020     |     www.medigraphic.com